Follow @BiologyFool
Recent articles
17 Consumer Groups and Unions Ask FTC to Block AbbVie's Acquisition of Allergan
The groups are worried about reduced competition if the merger goes through.
Want to Know What Your Heart Defibrillator Is Doing? Abbott Has an App for That
Remote monitoring should help doctors and patients identify issues earlier.
Pfizer Gains European Approval for Amyloidosis Drug Vyndaqel
Sales of the treatment got off to a good start in the U.S., and Europe could follow suit.
Sanofi Gets Backing From U.S. Government to Develop a COVID-19 Vaccine
The French drugmaker joins a host of other companies trying to develop vaccines and treatments for the coronavirus.
Johnson & Johnson Expands Pact With U.S. Government to Seek a Treatment for COVID-19
The government is also supporting the pharmaceutical giant's efforts to find a vaccine for the coronavirus.
FDA Approves 3 Drugs for the Switch From Prescription to Over the Counter
The switch will increase the availability of pain and allergy drugs from GlaxoSmithKline and Alcon.
The FDA Has a Plan to Deal With the Coronavirus
The COVID-19 virus is putting a wrinkle in the agency's activities.
FDA Asks That Weight Loss Drug Belviq Be Pulled From the Market
A study finds an increased risk of cancer, and the manufacturer complies with the FDA's request.
White House Claims Other Countries Are "Free-Riding" on U.S. Drug Development
It's gotten worse over the last 15 years.
Here's Why Inovio Pharmaceuticals Stock Rocketed Higher Today
The biotech could start testing its coronavirus vaccine as early as this summer.
FDA Gives Bristol-Myers Squibb's CAR-T Liso-Cel a Priority Review
A decision on the cancer therapy is expected by Aug. 17.
Eli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in Eczema
The drug moves closer to an expanded approval for the skin disorder.
FDA Confirms There's No Evidence That Cell Phones Cause Cancer
A new report from the agency reviewed nearly 200 studies published on the subject over more than a decade.
Here's Why Moderna Slipped Lower Today
A secondary offering causes dilution for the biotech.
Merck's Keytruda Helps Treat an Aggressive Form of Breast Cancer
Another win for the seeming unstoppable drug -- this time in metastatic triple-negative breast cancer.
Trump Wants a New Agency to Oversee Tobacco Products
The move would strip the Food and Drug Administration of the duty it's held for more than a decade.
Myovant's Uterine Fibroid Drug Relugolix Produces Positive Data in a Long-Term Study
The results were consistent with a pair of shorter studies of the combination treatment.
Here's Why Inovio Pharmaceuticals Jumped Higher Today
The company is starting a new clinical trial, but that may not be the only thing boosting the biotech's shares.
![Gottlieb[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F557081%2Fgottlieb1.jpg&w=479&h=281&op=resize)
Illumina Adds Former FDA Commissioner Scott Gottlieb to Its Board of Directors
The move should be helpful as the DNA-sequencing specialist develops diagnostic tests that require his former agency's approval.
Zogenix's Positive Clinical Trial Wasn't Positive Enough
Rival GW Pharmaceuticals came out the big winner, as its competing seizure drug looks more effective.